EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies

Wamidh H Talib iD, Suha M Sabri, Rawan W Hadi, Viktória Prémusz iD, Tamás Beregi iD

Nutrients · 2025

DOI: 10.3390/nu17193120 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2025. Verfasst von Wamidh H Talib und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931-166, Jordan. Hauptthemen laut MEDLINE: Melatonin, Neoplasms, Vitamins, Antioxidants. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Applied Science Private University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a major global health challenge, requiring new adjunctive therapies. Integrative oncology, which combines conventional treatments with complementary agents, has gained attention for improving patient outcomes. Melatonin, a potent antioxidant and immunomodulator, has shown promise in cancer therapy. Recent evidence suggests that combining melatonin with vitamins—particularly vitamin D, vitamin C, and vitamin E—may enhance its anticancer effects through synergistic mechanisms. Melatonin exerts anticancer effects by regulating oxidative stress, apoptosis, and immune responses. Vitamin D enhances immune modulation, while vitamins C and E provide antioxidant and cytoprotective benefits. Their combined action may improve tumor suppression and reduce treatment-induced toxicity. However, despite promising preclinical data, clinical studies on melatonin–vitamins synergy remain limited. This review explores the molecular interactions, current evidence, and research gaps in melatonin–vitamin combinations for cancer therapy. Future studies should focus on mechanistic insights, optimal dosing, and clinical trials to establish their role in integrative oncology. Unlocking this potential could enhance existing cancer treatment strategies and improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelatoninNeoplasmsVitaminsAntioxidantsAntineoplastic AgentsHumansVitamin DAnimalsOxidative StressDrug SynergismAscorbic AcidVitamin EDrug Therapy, Combination

Stichwörter der Autor:innen

combination anticancer therapyvitamin Cvitamin Dvitamin E

Substanzen

MelatoninVitaminsAntioxidantsVitamin DAntineoplastic AgentsAscorbic AcidVitamin E

Autor:innen und Institutionen

  • Faculty of Allied Medical Sciences, Applied Science Private University, Amman 11931-166, Jordan.
  • Department of Clinical Nutrition and Dietetics, Applied Science Private University, Amman 11931-166, Jordan.
  • Institute of Physiotherapy and Sports Science, Faculty of Health Sciences, University of Pécs, H-7621 Pécs, Hungary.
  • Physical Activity Research Group, János Szentágothai Research Center, National Laboratory on Human Reproduction, University of Pécs, H-7624 Pécs, Hungary.

ORCID-Profile: Wamidh H Talib, Viktória Prémusz, Tamás Beregi

Förderung

  • Applied Science Private University

Zitieren

APA

Talib, W. H., Sabri, S. M., Hadi, R. W., Prémusz, V., & Beregi, T. (2025). Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies. Nutrients. https://doi.org/10.3390/nu17193120

Vancouver

Talib WH, Sabri SM, Hadi RW, Prémusz V, Beregi T. Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies. Nutrients. 2025. doi:10.3390/nu17193120

BibTeX
@article{Talib2025,
  author = {Talib, Wamidh H and Sabri, Suha M and Hadi, Rawan W and Prémusz, Viktória and Beregi, Tamás},
  title = {Melatonin and Vitamins: A Promising Combination to Augment Conventional Anticancer Therapies},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17193120}
}
Kostenlos starten →